Walaa Said Dabbas

Walaa Dabbas practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Walaa Dabbas' NPI, 1417474669, was assigned on August 28, 2017. Walaa Dabbas holds Illinois license 036150662.

Walaa Dabbas' primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Walaa Dabbas' primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. Walaa Dabbas is also affiliated with Evanston Hospital. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Walaa Dabbas to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Walaa Dabbas practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Walaa Dabbas' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Walaa Dabbas is licensed in Illinois.

CMS data shows 608 Medicare services from Walaa Dabbas across 5 procedure codes in 2024, for 238 Medicare patients. Medicare paid $65,000 for them.

CMS counts 238 Medicare patients who saw Walaa Dabbas in 2024. The largest group is under 65, with 166 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 61% are also on Medicaid. Their average risk score is 6.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Walaa Dabbas' median patient age at 54, with 46% women.

In 2024, Walaa Dabbas wrote 3,934 Medicare Part D claims for 326 patients. 88% of them were for generic drugs. CMS names the drug for 3,621 of them, across 50 drugs with 11 or more claims each, at $745,988 in total drug cost. In 2023, CMS named 2,929 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Walaa Dabbas for performance year 2024, reported as part of a group. Walaa Dabbas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Walaa Dabbas as offering telehealth.

Dmand AI links 4 papers to Walaa Dabbas, published from 2015 to 2025. Walaa Dabbas' most frequent co-authors are Enrico Benedetti, MD, James P. Lash and Lakshmi Kant Pathak, MD.

CMS Open Payments shows 18 general payments to Walaa Dabbas from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 90% of the total. Travere Therapeutics, Inc. paid the most, $201.